Experimental models of pancreas cancer: what has been the impact for precision medicine? is a research paper published in Journal of Clinical Investigation (2025). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: T32 CA009370
NCI NIH HHS
Grant: P01 CA265762
NCI NIH HHS
Grant: F31 CA294995
National Institutes of Health
Grant: 1F31CA294995-01A1
Investigating the Role of Fibulin 3 in Pancreatic Tumorigenesis
National Institutes of Health
Grant: 5T32CA009370-06
CELL REGULATION DIFFERENTIATION AND CANCER
FWCI
3.35
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals